Markus Kraemer
Markus Kraemer
Alfried Krupp Hospital
Verified email at - Homepage
Cited by
Cited by
Social cognition in attention-deficit hyperactivity disorder (ADHD)
J Uekermann, M Kraemer, M Abdel-Hamid, BG Schimmelmann, ...
Neuroscience & biobehavioral reviews 34 (5), 734-743, 2010
Moyamoya disease in Europeans
M Kraemer, W Heienbrok, P Berlit
Stroke 39 (12), 3193-3200, 2008
Diagnostic problems and delay of diagnosis in amyotrophic lateral sclerosis
M Kraemer, M Buerger, P Berlit
Clinical neurology and neurosurgery 112 (2), 103-105, 2010
The spectrum of differential diagnosis in neurological patients with livedo reticularis and livedo racemosa
M Kraemer, D Linden, P Berlit
Journal of neurology 252 (10), 1155-1166, 2005
Neurologic complications of acute and chronic renal disease
MW Baumgaertel, M Kraemer, P Berlit
Handbook of clinical neurology 119, 383-393, 2014
German validation of the Conners Adult ADHD Rating Scales (CAARS) II: Reliability, validity, diagnostic sensitivity and specificity
H Christiansen, B Kis, O Hirsch, S Matthies, J Hebebrand, J Uekermann, ...
European Psychiatry 27 (5), 321-328, 2012
Genetic predisposition in anti‐LGI1 and anti‐NMDA receptor encephalitis
SH Mueller, A Färber, H Prüss, N Melzer, KS Golombeck, T Kümpfel, ...
Annals of neurology 83 (4), 863-869, 2018
Theory of mind and empathy in patients at an early stage of relapsing remitting multiple sclerosis
M Kraemer, M Herold, J Uekermann, B Kis, J Wiltfang, I Daum, I Dziobek, ...
Clinical neurology and neurosurgery 115 (7), 1016-1022, 2013
Methylphenidate-induced psychosis in adult attention-deficit/hyperactivity disorder: report of 3 new cases and review of the literature
M Kraemer, J Uekermann, J Wiltfang, B Kis
Clinical neuropharmacology 33 (4), 204-206, 2010
Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls
P Berlit, M Kraemer
Clinical & Experimental Immunology 175 (3), 419-424, 2014
Primary central nervous system vasculitis: clinical experiences with 21 new European cases
M Kraemer, P Berlit
Rheumatology international 31 (4), 463-472, 2011
Research progresses in understanding the pathophysiology of Moyamoya disease
A Bersano, S Guey, G Bedini, S Nava, D Hervé, P Vajkoczy, T Tatlisumak, ...
Cerebrovascular diseases 41 (3-4), 105-118, 2016
Stroke care during the COVID‐19 pandemic: experience from three large European countries
A Bersano, M Kraemer, E Touzé, R Weber, S Alamowitch, I Sibon, ...
European journal of neurology 27 (9), 1794-1800, 2020
What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey
M Kraemer, P Berlit, F Diesner, N Khan
European journal of neurology 19 (1), 163-167, 2012
Retinal pathology in Susac syndrome detected by spectral-domain optical coherence tomography
M Ringelstein, P Albrecht, I Kleffner, B Bühn, J Harmel, AK Müller, D Finis, ...
Neurology 85 (7), 610-618, 2015
Visual evoked potentials in neuromyelitis optica and its spectrum disorders
M Ringelstein, I Kleiter, I Ayzenberg, N Borisow, F Paul, K Ruprecht, ...
Multiple Sclerosis Journal 20 (5), 617-620, 2014
Primary central nervous system vasculitis and moyamoya disease: similarities and differences
M Kraemer, P Berlit
Journal of neurology 257 (5), 816-819, 2010
Systemic, secondary and infectious causes for cerebral vasculitis: clinical experience with 16 new European cases
M Kraemer, P Berlit
Rheumatology international 30 (11), 1471-1476, 2010
Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians
S Guey, M Kraemer, D Hervé, T Ludwig, M Kossorotoff, F Bergametti, ...
European Journal of Human Genetics 25 (8), 995-1003, 2017
German validation of the Conners Adult ADHD Rating Scale–Self-Report: confirmation of factor structure in a large sample of participants with ADHD
H Christiansen, O Hirsch, A Philipsen, RD Oades, S Matthies, ...
Journal of attention disorders 17 (8), 690-698, 2013
The system can't perform the operation now. Try again later.
Articles 1–20